Optiver Holding’s CervoMed CRVO Stock Holding History

Optiver Holding’s Portfolio CRVO Stock Details CRVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$39	Hold	10	–	–	﹤0.01%	2263
2025 Q4	$79	Hold	10	–	–	﹤0.01%	2379
2025 Q3	$81	Buy	+10	New	+$86	﹤0.01%	2602

Other funds holding CRVO

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

CFG

Citizens Financial Group Providence, Rhode Island $7.19B AUM 23.93% 1-Year Est. Return

VFT

Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Optiver Holding's CRVO Position: Q1 2026 in Review

Optiver Holding held its CervoMed (CRVO) position steady in Q1 2026 at 10 shares worth $39. The position accounts for ﹤0.01% of the portfolio, ranked #2263.

Optiver Holding first reported a position in CRVO in Q3 2025 and has held it in 3 quarters since. The position peaked at $81 in Q3 2025. 36 funds tracked by Wall St. Rank hold CRVO as of Q1 2026.

Optiver Holding held 10 shares of CervoMed worth $39 as of Q1 2026.
Optiver Holding left its CervoMed share count unchanged in Q1 2026.
CervoMed made up ﹤0.01% of Optiver Holding's portfolio in Q1 2026, its #2263 holding.
Optiver Holding first reported a position in CervoMed in Q3 2025 and has held it in 3 quarters since.
Optiver Holding's CervoMed position peaked at $81 in Q3 2025.
36 funds tracked by Wall St. Rank held CervoMed as of Q1 2026.

Based on Optiver Holding's 13F filing for Q1 2026, filed 15 May 2026.